180 related articles for article (PubMed ID: 1417020)
1. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B
Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Shephard SE; Panizzon RG
Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
4. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
Halder RM; Battle EF; Smith EM
Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
[No Abstract] [Full Text] [Related]
6. Bath PUVA--an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater.
Wainwright NJ; MacLeod TM; Ferguson J
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):17-20. PubMed ID: 9361123
[TBL] [Abstract][Full Text] [Related]
7. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
Koulu L; Jansén CT
Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
[TBL] [Abstract][Full Text] [Related]
8. PUVA therapy for polymorphous light eruptions: comparison of systemic methoxsalen and topical trioxsalen regimens and evaluation of local protective mechanisms.
Jansén CT; Karvonen J; Malmiharju T
Acta Derm Venereol; 1982; 62(4):317-20. PubMed ID: 6183864
[TBL] [Abstract][Full Text] [Related]
9. The carcinogenic properties of topical PUVA. A lifelong study in mice.
Hannuksela M; Stenbäck F; Lahti A
Arch Dermatol Res; 1986; 278(5):347-51. PubMed ID: 3753032
[TBL] [Abstract][Full Text] [Related]
10. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
12. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
Turjanmaa K; Salo H; Reunala T
Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
[TBL] [Abstract][Full Text] [Related]
13. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy.
van Coevorden AM; Kamphof WG; van Sonderen E; Bruynzeel DP; Coenraads PJ
Arch Dermatol; 2004 Dec; 140(12):1463-6. PubMed ID: 15611423
[TBL] [Abstract][Full Text] [Related]
17. The effect of PUVA on langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen.
Kuusilehto A; Happonen RP; Peltola J; Lehtinen R; Jansén CT
Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):129-33. PubMed ID: 10885443
[TBL] [Abstract][Full Text] [Related]
18. PUVA and cancer risk: the Swedish follow-up study.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
[TBL] [Abstract][Full Text] [Related]
19. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
[TBL] [Abstract][Full Text] [Related]
20. Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.
Stern RS; Nichols KT
J Pediatr; 1996 Dec; 129(6):915-7. PubMed ID: 8969737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
